tiprankstipranks
Advertisement
Advertisement

KPRX Stock Latest News

Strategic Financing and Differentiated KIO‑301 Pipeline Underpin Buy Rating on Kiora Pharmaceuticals (KPRX)
RatingsStrategic Financing and Differentiated KIO‑301 Pipeline Underpin Buy Rating on Kiora Pharmaceuticals (KPRX)
6d ago
KPRX
Kiora Pharmaceuticals Announces $5 Million Private Placement Financing
PremiumCompany Announcements
Kiora Pharmaceuticals Announces $5 Million Private Placement Financing
7d ago
8K
KPRX
Kiora Pharmaceuticals Announces Chief Development Officer Resignation
PremiumCompany Announcements
Kiora Pharmaceuticals Announces Chief Development Officer Resignation
12d ago
8K
KPRX
Clinical and Market Validation of Kiora’s Lead Programs Underpin Buy Rating and $12 Price Target
PremiumRatings
Clinical and Market Validation of Kiora’s Lead Programs Underpin Buy Rating and $12 Price Target
2M ago
KPRX
Kiora Pharmaceuticals: Strong Financial Position and Promising Clinical Developments Drive Buy Rating
PremiumRatings
Kiora Pharmaceuticals: Strong Financial Position and Promising Clinical Developments Drive Buy Rating
5M ago
KPRX
Kiora Pharmaceuticals Reports Improved Financial Performance
PremiumCompany AnnouncementsKiora Pharmaceuticals Reports Improved Financial Performance
5M ago
KPRX
Kiora Pharmaceuticals Advances Phase II Study for Retinitis Pigmentosa Treatment
Premium
Company Announcements
Kiora Pharmaceuticals Advances Phase II Study for Retinitis Pigmentosa Treatment
6M ago
KPRX
Kiora Pharmaceuticals Advances Promising Eye Treatment with KIO-301 Study
Premium
Company Announcements
Kiora Pharmaceuticals Advances Promising Eye Treatment with KIO-301 Study
6M ago
KPRX
Kiora Pharmaceuticals’ KIO-104: A Promising Treatment for Macular Edema?
PremiumCompany Announcements
Kiora Pharmaceuticals’ KIO-104: A Promising Treatment for Macular Edema?
6M ago
KPRX
Kiora Pharmaceuticals files $100M mixed securities shelf
PremiumThe Fly
Kiora Pharmaceuticals files $100M mixed securities shelf
7M ago
KPRX
Kiora Pharmaceuticals Highlights at Ophthalmology Conference
PremiumCompany Announcements
Kiora Pharmaceuticals Highlights at Ophthalmology Conference
8M ago
8K
KPRX
Promising Developments and Strategic Partnerships Drive Buy Rating for Kiora Pharmaceuticals
PremiumRatings
Promising Developments and Strategic Partnerships Drive Buy Rating for Kiora Pharmaceuticals
8M ago
KPRX
Kiora Pharmaceuticals Advances Retinal Disease Pipeline
PremiumCompany AnnouncementsKiora Pharmaceuticals Advances Retinal Disease Pipeline
8M ago
KPRX
Positive Outlook for Kiora Pharmaceuticals: Buy Rating Affirmed Amid Promising Developments and Strategic Initiatives
Premium
Ratings
Positive Outlook for Kiora Pharmaceuticals: Buy Rating Affirmed Amid Promising Developments and Strategic Initiatives
9M ago
KPRX
Kiora Pharmaceuticals granted new patent for KIO-104, says H.C. Wainwright
Premium
The Fly
Kiora Pharmaceuticals granted new patent for KIO-104, says H.C. Wainwright
9M ago
KPRX
Kiora Pharmaceuticals Holds Annual Meeting, Elects Directors
PremiumCompany Announcements
Kiora Pharmaceuticals Holds Annual Meeting, Elects Directors
10M ago
8K
KPRX
Kiora Pharmaceuticals: Strategic Partnerships and Promising Financial Prospects Drive Buy Rating
PremiumRatings
Kiora Pharmaceuticals: Strategic Partnerships and Promising Financial Prospects Drive Buy Rating
10M ago
KPRX
Kiora Pharmaceuticals Secures Exclusive Option Agreement with Senju
PremiumCompany Announcements
Kiora Pharmaceuticals Secures Exclusive Option Agreement with Senju
11M ago
8K
KPRX
Kiora Pharmaceuticals Reports Q1 2025 Financial Results
PremiumCompany Announcements
Kiora Pharmaceuticals Reports Q1 2025 Financial Results
11M ago
KPRX
Kiora Pharmaceuticals: Strong Financial Position and Strategic Partnerships Propel Buy Rating
PremiumRatingsKiora Pharmaceuticals: Strong Financial Position and Strategic Partnerships Propel Buy Rating
11M ago
KPRX
Kiora Pharmaceuticals’ KIO-104: Promising Preclinical Data and Strong Buy Rating
Premium
Ratings
Kiora Pharmaceuticals’ KIO-104: Promising Preclinical Data and Strong Buy Rating
11M ago
KPRX
Kiora Pharmaceuticals, Inc. (KPRX) Q1 Earnings Cheat Sheet
Premium
Pre-Earnings
Kiora Pharmaceuticals, Inc. (KPRX) Q1 Earnings Cheat Sheet
11M ago
KPRX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >